Literature DB >> 12914688

Invertebrate models of neurologic disease: insights into pathogenesis and therapy.

Leslie Michels Thompson1, J Lawrence Marsh.   

Abstract

The search for cures of human diseases can be very slow, expensive, and serendipitous. Roughly five decades of basic research in a handful of model systems has revealed that most animals are quite similar to one another especially at the cellular and molecular levels. The commonalities allow one to use animal models to investigate human disease mechanisms. Here, we review contributions demonstrating the use of invertebrate models to investigate human neurodegenerative diseases. We conclude that the integration of fly and worm models into programs seeking to identify therapeutic strategies for neurodegenerative disease can significantly speed progress toward finding cures for these devastating diseases.

Entities:  

Mesh:

Year:  2003        PMID: 12914688     DOI: 10.1007/s11910-003-0028-7

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  59 in total

1.  Parkinson's pathology in a fly.

Authors:  C Haass; P J Kahle
Journal:  Nature       Date:  2000-03-23       Impact factor: 49.962

2.  Teaching old drugs new tricks. Meeting of the Neurodegeneration Drug Screening Consortium, 7-8 April 2002, Washington, DC, USA.

Authors:  Jill Heemskerk; Allan J Tobin; Lisa J Bain
Journal:  Trends Neurosci       Date:  2002-10       Impact factor: 13.837

3.  Genetic suppression of polyglutamine toxicity in Drosophila.

Authors:  P Kazemi-Esfarjani; S Benzer
Journal:  Science       Date:  2000-03-10       Impact factor: 47.728

4.  Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila.

Authors:  Ken-ichi Takeyama; Saya Ito; Ayako Yamamoto; Hiromu Tanimoto; Takashi Furutani; Hirotaka Kanuka; Masayuki Miura; Tetsuya Tabata; Shigeaki Kato
Journal:  Neuron       Date:  2002-08-29       Impact factor: 17.173

Review 5.  Glutamine repeats and neurodegeneration.

Authors:  H Y Zoghbi; H T Orr
Journal:  Annu Rev Neurosci       Date:  2000       Impact factor: 12.449

6.  blue cheese mutations define a novel, conserved gene involved in progressive neural degeneration.

Authors:  Kim D Finley; Philip T Edeen; Robert C Cumming; Michelle D Mardahl-Dumesnil; Barbara J Taylor; Maria H Rodriguez; Calvin E Hwang; Michael Benedetti; Michael McKeown
Journal:  J Neurosci       Date:  2003-02-15       Impact factor: 6.167

7.  Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.

Authors:  J S Steffan; L Bodai; J Pallos; M Poelman; A McCampbell; B L Apostol; A Kazantsev; E Schmidt; Y Z Zhu; M Greenwald; R Kurokawa; D E Housman; G R Jackson; J L Marsh; L M Thompson
Journal:  Nature       Date:  2001-10-18       Impact factor: 49.962

8.  Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders.

Authors:  Ivelisse Sánchez; Christian Mahlke; Junying Yuan
Journal:  Nature       Date:  2003-01-23       Impact factor: 49.962

9.  Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human alpha-synuclein.

Authors:  Merja Lakso; Suvi Vartiainen; Anu-Maarit Moilanen; Jouni Sirviö; James H Thomas; Richard Nass; Randy D Blakely; Garry Wong
Journal:  J Neurochem       Date:  2003-07       Impact factor: 5.372

10.  Targeted gene expression as a means of altering cell fates and generating dominant phenotypes.

Authors:  A H Brand; N Perrimon
Journal:  Development       Date:  1993-06       Impact factor: 6.868

View more
  2 in total

Review 1.  Modeling human neurodegenerative diseases in transgenic systems.

Authors:  Miguel A Gama Sosa; Rita De Gasperi; Gregory A Elder
Journal:  Hum Genet       Date:  2011-12-14       Impact factor: 4.132

2.  Two distinct evolutionary conserved neural degeneration pathways characterized in a colonial chordate.

Authors:  Chiara Anselmi; Mark Kowarsky; Fabio Gasparini; Federico Caicci; Katherine J Ishizuka; Karla J Palmeri; Tal Raveh; Rahul Sinha; Norma Neff; Stephen R Quake; Irving L Weissman; Ayelet Voskoboynik; Lucia Manni
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-11       Impact factor: 12.779

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.